fda warning letter compounded semaglutide september 2025 hims and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown. What's Next? FDA's Coordinated Enforcement on GLP-1 – There's lots going on this

How much weight can a non-diabetic person lose with GLP-1 therapy

Implications for treatment and the future of personalized medicine This study underscores the need for including female subjects in pre-clinical studies, along with the potential of developing personalized dosing strategies for GLP-1 therapies

How to start GLP-1 treatment with Noom or Ro Starting a weight-loss program with either Noom or Ro begins with a structured intake process to determine if you qualify for GLP-1 medications or other treatment options

Available from: www.diabetes.org.uk/professionals/resources/resources-to-improve-your-clinical-practice/diabetes-self-management-education